Factors Influencing Readmission Rates of Acute Traumatic Subdural Hematoma in the Elderly
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03878043|
Recruitment Status : Completed
First Posted : March 18, 2019
Last Update Posted : March 21, 2019
|Condition or disease||Intervention/treatment|
|Traumatic Subdural Hematoma||Other: Follow-up Care|
|Study Type :||Observational|
|Actual Enrollment :||167 participants|
|Official Title:||A Retrospective Analysis of Factors Influencing Readmission Rates of Acute Traumatic Subdural Hematoma in the Elderly|
|Actual Study Start Date :||January 2014|
|Actual Primary Completion Date :||December 2016|
|Actual Study Completion Date :||March 2019|
Patients without Readmissions
Patients with TSDH who were not readmitted within a 6-month time period following their initial visit.
Patients with Readmissions
Patients with TSDH who were readmitted within a 6-month time period following their initial visit.
Other: Follow-up Care
Follow up care provided upon readmission to patients who were diagnosed with a TSDH upon initial visit.
- Number of participants readmitted to the hospital [ Time Frame: 6 months ]Number of patients diagnosed with TSDH who were readmitted to the hospital within a 6 month time frame
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03878043
|United States, Michigan|
|Genesys Regional Medical Center|
|Grand Blanc, Michigan, United States, 48439|
|Principal Investigator:||Tarik Wasfie, MD||Genesys Regional Medical Center|